FLUIDDA

📍 New York, United States🗓 Founded 2005👥 33 employees💰 Last funded Aug 2022
FLUIDDA’s main acitivities consist of developing imaging biomarkers to enhance drug development and patient care. These biomarkers combine biomedical imaging and advanced engineering methods. It has been demonstrated in recent studies that this novel approach yields sensitive outcome parameters to detect physiological or clinical changes in patients following an intervention. This provides additional insight into the mode of action of the intervention and allows for optimization of the therapy and improved patient selection. To support the implementation of this novel method into clinical studies and clinical practice, FLUIDDA also offers a CRO service with the focus on imaging. A complete package can therefore be offered to the client from initial protocol writing to full data analysis using the advanced processing techniques. To offer a high quality service FLUIDDA employs experts in all required fields from medical doctors to biomedical scientists and engineers. #FRI #FunctionalRespiratoryImaging
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2005
Founded
Investor geography1 country
Austria
1
Frequently asked questions
Who invested in FLUIDDA?
FLUIDDA has 1 investors on record on gritt.io.
When did FLUIDDA last raise funding?
The most recent investment in FLUIDDA recorded on gritt.io was in August 2022.
When was FLUIDDA founded?
FLUIDDA was founded in 2005.
What industry is FLUIDDA in?
FLUIDDA operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is FLUIDDA based?
FLUIDDA is headquartered in New York, United States.